1 terminated, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Central Nervous System Sarcoma: new trials by email Literature Review of Central Nervous System Sarcoma trials Research Report on Central Nervous System Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord Placebo Administration, Questionnaire Administration, Wound Dressing Material - Central Nervous System Sarcoma, Ependymoma | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2019-08-19 | 2024-10-09 | |
| Sunitinib in Sarcomas of the Central Nervous System Sunitinib, wGT3x-BT - Gliosarcoma, Central Nervous System Sarcoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2019-02-21 | 2022-04-19 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Ependymoma (1) · Glioma (1) · Gliosarcoma (1) · Medulloblastoma (1) · Pinealoma (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neuroectodermal Tumors (2) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioma (1)
M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1)
United States (2)
Mark R Gilbert, M.D. (1) · Susan L McGovern (1)